Literature DB >> 21378558

Management of postcardiac arrest myocardial dysfunction.

Ayhan Zia1, Karl B Kern.   

Abstract

PURPOSE OF REVIEW: Recent recognition of the importance of postresuscitation care has stimulated interest and new reports concerning therapies for postcardiac arrest myocardial dysfunction. Such cardiac dysfunction after successful resuscitation can be severe and even lethal; however, it is also transient emphasizing the importance of early supportive therapies. RECENT
FINDINGS: The most important strategies for dealing with postresuscitation myocardial dysfunction include a community-formalized effort by individual communities to shorten the time from arrest to restoration of spontaneous circulation, use of therapeutic hypothermia for myocardial preservation, not just cerebral, and early coronary angiography and intervention for all survivors with a high suspicion of a cardiac cause for their arrest. Exciting specific therapies targeted for one or another of the ischemia/reperfusion myocardial injuries associated with cardiac arrest include manipulation of the nitric oxide production in the myocardium, treatment of myocardial microcirculatory dysfunction post resuscitation, inhibition of Na+/H+ exchange, and treatment of calcium flux abnormalities.
SUMMARY: Every community should be striving to provide more timely restoration of pulse and circulation, whereas every medical center receiving patients resuscitated from out-of-hospital cardiac arrest should be providing therapeutic hypothermia for both central nervous system and myocardial preservation. The ability and commitment to provide '24/7' early coronary angiography and percutaneous intervention for all resuscitated victims of sudden cardiac death with a likely cardiac cause for their arrest is also key.

Entities:  

Mesh:

Year:  2011        PMID: 21378558     DOI: 10.1097/MCC.0b013e3283447759

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  10 in total

Review 1.  Cardiopulmonary resuscitation and management of cardiac arrest.

Authors:  Jerry P Nolan; Jasmeet Soar; Volker Wenzel; Peter Paal
Journal:  Nat Rev Cardiol       Date:  2012-06-05       Impact factor: 32.419

2.  Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension.

Authors:  Lian Tian; Monica Neuber-Hess; Jeffrey Mewburn; Asish Dasgupta; Kimberly Dunham-Snary; Danchen Wu; Kuang-Hueih Chen; Zhigang Hong; Willard W Sharp; Shelby Kutty; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2017-03-06       Impact factor: 4.599

3.  In Vivo Post-Cardiac Arrest Myocardial Dysfunction Is Supported by Ca2+/Calmodulin-Dependent Protein Kinase II-Mediated Calcium Long-Term Potentiation and Mitigated by Alda-1, an Agonist of Aldehyde Dehydrogenase Type 2.

Authors:  Christopher Woods; Ching Shang; Fouad Taghavi; Peter Downey; Adrian Zalewski; Gabriel R Rubio; Jing Liu; Julian R Homburger; Zachary Grunwald; Wei Qi; Christian Bollensdorff; Porama Thanaporn; Ayyaz Ali; Kirk Riemer; Peter Kohl; Daria Mochly-Rosen; Edward Gerstenfeld; Stephen Large; Ziad Ali; Euan Ashley
Journal:  Circulation       Date:  2016-08-31       Impact factor: 29.690

4.  Lipid emulsion rapidly restores contractility in stunned mouse cardiomyocytes: a comparison with therapeutic hypothermia.

Authors:  Jing Li; Michael Fettiplace; Sy-Jou Chen; Benjamin Steinhorn; Zuohui Shao; Xiangdong Zhu; Changqing Li; Shaun Harty; Guy Weinberg; Terry L Vanden Hoek
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

5.  TNF-α blockade improves early post-resuscitation survival and hemodynamics in a swine model of ischemic ventricular fibrillation.

Authors:  James T Niemann; Scott T Youngquist; Atman P Shah; Joseph L Thomas; John P Rosborough
Journal:  Resuscitation       Date:  2012-06-07       Impact factor: 5.262

6.  A novel pharmacological strategy by PTEN inhibition for improving metabolic resuscitation and survival after mouse cardiac arrest.

Authors:  Jing Li; Huashan Wang; Qiang Zhong; Xiangdong Zhu; Sy-Jou Chen; Yuanyu Qian; Jim Costakis; Gabrielle Bunney; David G Beiser; Alan R Leff; E Douglas Lewandowski; J Michael ÓDonnell; Terry L Vanden Hoek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-20       Impact factor: 4.733

7.  Inhibition of the mitochondrial fission protein dynamin-related protein 1 improves survival in a murine cardiac arrest model.

Authors:  Willard W Sharp; David G Beiser; Yong Hu Fang; Mei Han; Lin Piao; Justin Varughese; Stephen L Archer
Journal:  Crit Care Med       Date:  2015-02       Impact factor: 7.598

8.  Takotsubo syndrome in a premenopausal patient.

Authors:  Maria Menezes; Daniela Marto; Isabel Marcão; Catarina Salvado
Journal:  BMJ Case Rep       Date:  2018-02-17

9.  Shen-Fu Injection () alleviates post-resuscitation myocardial dysfunction by up-regulating expression of sarcoplasmic reticulum Ca(2+)-ATPase.

Authors:  Zhi-Jun Guo; Cai-Jun Wu; Chun-Sheng Li
Journal:  Chin J Integr Med       Date:  2015-08-11       Impact factor: 1.978

10.  Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation.

Authors:  P Markowski; O Boehm; L Goelz; A L Haesner; H Ehrentraut; K Bauerfeld; N Tran; K Zacharowski; C Weisheit; P Langhoff; M Schwederski; T Hilbert; S Klaschik; A Hoeft; G Baumgarten; R Meyer; P Knuefermann
Journal:  Basic Res Cardiol       Date:  2013-08-09       Impact factor: 17.165

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.